MentionFox
Home › funding signals › Dermata Therapeutics, Inc.
Company · SEC filings

Dermata Therapeutics, Inc. funding history

Before you sign with, sell to or invest in Dermata Therapeutics, Inc.

MentionFox check on Dermata Therapeutics, Inc.: no red flags found in 6 sources (checked 17 November 2026). mentionfox.com/c/company/dermata-therapeutics-inc

Check Dermata Therapeutics, Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Dermata Therapeutics, Inc.?

Dermata Therapeutics, Inc. has 5 Form D filings on record, from 2023-06-12 to 2026-01-07. Together its new offerings report $10.17M sold.

In its own words: “Tome is a skincare company forging a timeless ingredient with modern science to bring a first-of-its-kind, weekly treatment made for home.” (tomeskincare.com, checked November 1, 2026)

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Dermata Therapeutics, Inc.: Raised $4.12M, Form D filed 2026-01-07
Share on LinkedIn Share on X Download image

Keep reading

More on Dermata Therapeutics, Inc. and the records around it.

Dermata Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Dermata Therapeutics, Inc.?

Key facts

  • · Type: New offering first sale 2025-12-29 · Amount sold: $4.12M · Total offering: $4.12M · SEC filing
  • · Type: Amendment first sale 2025-01-21 · Amount sold: $2.55M · Total offering: $2.55M · SEC filing
  • · Type: New offering first sale 2025-01-21 · Amount sold: $2.55M · Total offering: $2.55M · SEC filing
  • · Type: New offering first sale 2024-09-17 · Amount sold: $3.50M · Total offering: $3.50M · SEC filing
  • · Type: New offering first sale 2023-05-26 · Amount sold: $0 · SEC filing

Is Dermata Therapeutics, Inc. a real, registered company?

Dermata Therapeutics, Inc. is a registered filer with the SEC (CIK 1853816) and has filed since 2023-06-12. 5 filings are on record, the latest on 2026-01-07.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Dermata Therapeutics, Inc.?

Dermata Therapeutics, Inc.'s filings name Andrew Sandler, Brittany Bradrick, Christopher Nardo and 8 more as its officers, directors or promoters.

How much has Dermata Therapeutics, Inc. raised?

Its new offerings report $10.17M sold across 3 offerings, as its own filings state.

Run the free check on Dermata Therapeutics, Inc. →

Based
SAN DIEGO, CALIFORNIA
Year formed
2021
Industry group
Biotechnology
Filings
5
Raised (new offerings)
$10.17M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-01-07New offering
first sale 2025-12-29
$4.12M$4.12Mdetails · SEC filing
2025-02-04Amendment
first sale 2025-01-21
$2.55M$2.55MSEC filing
2025-01-28New offering
first sale 2025-01-21
$2.55M$2.55Mdetails · SEC filing
2024-09-27New offering
first sale 2024-09-17
$3.50M$3.50MSEC filing
2023-06-12New offering
first sale 2023-05-26
$0—SEC filing

Want the whole picture on Dermata Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Dermata Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Dermata Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    6 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Dermata Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Follow this company

Tools for this story

Each opens in a new tab, filled in for Dermata Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/dermata-therapeutics-inc
Last updated 2026-11-17
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
How much has Dermata Therapeutics, Inc. raised? $10.17M in 5 SEC filings. MentionFox, 2026-11-17. https://mentionfox.com/company/dermata-therapeutics-inc